Effect of the Dietary Supplement Taxifolin Aqua on the Recovery Period After COVID-19 Pneumonia
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04871802 |
Recruitment Status : Unknown
Verified March 2021 by Pirogov Russian National Research Medical University.
Recruitment status was: Not yet recruiting
First Posted : May 4, 2021
Last Update Posted : May 4, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Covid19 | Dietary Supplement: Taxifolin Aqua | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 100 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | A Prospective, Randomized, Comparative Study in Two Groups to Assess the Effect of the Use of a Dietary Supplement Taxifolin Aqua on the Recovery Period After COVID Pneumonia and on the Biological Age |
Estimated Study Start Date : | May 10, 2021 |
Estimated Primary Completion Date : | September 1, 2021 |
Estimated Study Completion Date : | October 1, 2021 |
Arm | Intervention/treatment |
---|---|
Experimental: Taxifolin Aqua group
Taxifolin Aqua 30 mg per day in addition to standard therapy
|
Dietary Supplement: Taxifolin Aqua
Dietary supplement |
No Intervention: Control group
No intervention
|
- Dynamics of spirometry indices [ Time Frame: In 2 months after recruitment ]spirometry
- Dynamics of ECHO CG [ Time Frame: In 2 months after recruitment ]ECHO CG
- Dynamics of pulse wave velocity [ Time Frame: In 2 months after recruitment ]applanation tonometry
- Dynamics of augmentation index [ Time Frame: In 2 months after recruitment ]applanation tonometry
- Dynamics of biological age [ Time Frame: In 2 months after recruitment ]Laboratory indicators
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Patients of both sexes who had covid pneumonia 3 months ago and signed an informed consent and aged 18+.
Exclusion Criteria:
Standard contraindications to Taxifolin Aqua use.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04871802
Contact: Irina Strazhesko, MD, PhD | Istrazhesko@gmail.com | ||
Contact: Olga Tkacheva, MD, PhD | +74991871254 | rgnkc@rgnkc.ru |
Russian Federation | |
Russian Clinical Research Center for Gerontology | |
Moscow, Russian Federation, 129226 |
Principal Investigator: | Irina Strazhesko, MD, PhD | Clinical Reserach Center for Gerontology |
Responsible Party: | Pirogov Russian National Research Medical University |
ClinicalTrials.gov Identifier: | NCT04871802 |
Other Study ID Numbers: |
COVID-AQUA-1 |
First Posted: | May 4, 2021 Key Record Dates |
Last Update Posted: | May 4, 2021 |
Last Verified: | March 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
COVID-19 Pneumonia Pneumonia, Viral Respiratory Tract Infections Infections Virus Diseases Coronavirus Infections Coronaviridae Infections Nidovirales Infections RNA Virus Infections Lung Diseases |
Respiratory Tract Diseases Taxifolin Anti-Inflammatory Agents, Non-Steroidal Analgesics, Non-Narcotic Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anti-Inflammatory Agents Antirheumatic Agents |